Longitudinal reduction defect of ulna, bilateral
ICD-10 Q71.53 is a billable code used to indicate a diagnosis of longitudinal reduction defect of ulna, bilateral.
Longitudinal reduction defect of the ulna is a congenital malformation characterized by the underdevelopment or absence of the ulna bone in the forearm. When bilateral, both ulnae are affected, leading to significant functional impairment and potential deformities in the wrist and hand. This condition can result in a range of clinical manifestations, including limited range of motion, altered grip strength, and compensatory changes in the radius. Patients may also exhibit associated anomalies, such as clubfoot or scoliosis, due to the interconnected nature of musculoskeletal development. Diagnosis typically involves clinical examination and imaging studies, such as X-rays, to assess the extent of the defect and any associated skeletal abnormalities. Early intervention, including physical therapy and possible surgical correction, is crucial for optimizing functional outcomes and improving quality of life for affected individuals.
Detailed growth and development assessments, including physical examination findings and functional limitations.
Assessment of a child with bilateral ulna reduction defects presenting with wrist deformities and functional limitations.
Consideration of developmental milestones and the impact of the defect on daily activities.
Genetic testing results, family history of congenital conditions, and any syndromic associations.
Genetic counseling for families with a history of limb reduction defects and associated syndromes.
Understanding the genetic basis of congenital malformations and the implications for family planning.
Used in cases where surgical intervention is necessary to correct deformities associated with ulna reduction defects.
Detailed operative notes and pre-operative assessments.
Orthopedic specialists must document the rationale for surgical intervention.
Accurate coding of Q71.53 is crucial for ensuring appropriate reimbursement, tracking treatment outcomes, and facilitating research on congenital malformations. It also aids in the identification of associated conditions that may require multidisciplinary management.
